The stock of Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) last traded at $14.14, up 0.57% from the previous session.
TEVA stock price is now 11.05% away from the 50-day moving average and 39.91% away from the 200-day moving average. The market capitalization of the company currently stands at $15.85B.
With the price target maintained at $14, JP Morgan recently Upgraded its rating from Underweight to Neutral for Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA). On February 12, 2024, Piper Sandler Upgraded its previous ‘Neutral’ rating to ‘Overweight’ on the stock increasing its target price from $12 to quote $19, while ‘Jefferies’ rates the stock as ‘Buy’
In other news, Kalif Eliyahu Sharon, EVP, Chief Financial Officer sold 77,550 shares of the company’s stock on Mar 06 ’24. The stock was sold for $1,048,119 at an average price of $13.52. Upon completion of the transaction, the EVP, Chief Financial Officer now directly owns 203,691 shares in the company, valued at $2.88 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Mar 05 ’24, EVP, International Markets Sabag Mark sold 100,000 shares of the business’s stock. A total of $1,352,090 was realized by selling the stock at an average price of $13.52. This leaves the insider owning 382,590 shares of the company worth $5.41 million. A total of 0.01% of the company’s stock is owned by insiders.
During the past 12 months, Teva- Pharmaceutical Industries Ltd. ADR has had a low of $7.09 and a high of $14.17. As of last week, the company has a debt-to-equity ratio of 2.70, a current ratio of 1.02, and a quick ratio of 0.69. The fifty day moving average price for TEVA is $12.79 and a two-hundred day moving average price translates $10.14 for the stock.
The latest earnings results from Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) was released for Dec, 2023. According to the Drug Manufacturers – Specialty & Generic Company, earnings per share came in at $1, beating analysts’ expectations of $0.77 by 0.23. This compares to -$1.21 EPS in the same period last year. The net profit margin was -3.33% and return on equity was -6.84% for TEVA. The company reported revenue of $4.46 billion for the quarter, compared to $3.88 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 14.78 percent. For the current quarter, analysts expect TEVA to generate $3.76B in revenue.
